MovDisordV3, Main, Exploration, bibRecord, 005276

Proton magnetic resonance spectroscopy in steele‐richardson‐olszewski syndrome

Identifieur interne : 005276 ( Main/Exploration ); précédent : 005275; suivant : 005277

Proton magnetic resonance spectroscopy in steele‐richardson‐olszewski syndrome

Auteurs : Charles A. Davie [Royaume-Uni] ; Gareth J. Barker [Royaume-Uni] ; Christine Machado [Royaume-Uni] ; David H. Miller [Royaume-Uni] ; Lees [Royaume-Uni]

Source :

Movement Disorders [ 0885-3185 ] ; 1997-09.

RBID : ISTEX:2842B82D4079CFF7DD0CF850DC5599DA665D0A52

Descripteurs français

Pascal (Inist)
- Exploration, Homme, Imagerie RMN, Noyau gris central, Ophtalmoplégie supranucléaire, Progressif, Spectrométrie RMN.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Adult, Aged, Aspartic Acid (analogs & derivatives), Aspartic Acid (analysis), Basal Ganglia (chemistry), Basal Ganglia (pathology), Basal ganglia, Basal ganglion, Case-Control Studies, Choline (analysis), Creatine (analysis), Diagnosis, Differential, Exploration, Globus Pallidus (pathology), Human, Humans, Magnetic Resonance Imaging, Magnetic Resonance Spectroscopy, Magnetic resonance imaging, Middle Aged, NMR spectrometry, Nuclear magnetic resonance imaging, N‐acetylaspartate, Progressive, Progressive supranuclear palsy, Spectroscopy, Supranuclear Palsy, Progressive (diagnosis), Supranuclear ophthalmoplegia.
MESH :
- chemical , analogs & derivatives : Aspartic Acid.
- chemical , analysis : Aspartic Acid, Choline, Creatine.
- chemistry : Basal Ganglia.
- diagnosis : Supranuclear Palsy, Progressive.
- pathology : Basal Ganglia, Globus Pallidus.
- Adult, Aged, Case-Control Studies, Diagnosis, Differential, Humans, Magnetic Resonance Imaging, Magnetic Resonance Spectroscopy, Middle Aged.

Abstract

Proton magnetic resonance spectroscopy, localized to the lentiform nucleus, was carried out in nine patients with a clinical diagnosis of Steele‐Richardson‐Olszewski syndrome (SRO) and in eight healthy age‐matched controls. Three of the nine SRO patients had a so‐called “eye of the tiger sign” with high signal in the globus pallidus surrounded by a ring of low signal on T2 weighted magnetic resonance imaging previously only reported in Hallervorden‐Spatz disease. One of these patients had pathologically proven SRO at postmortem. The SRO group showed a significant reduction in the median concentration from N‐acetyl groups (median, 6.87 mM; range, 4.92–10.59 mM; p < 0.015) compared with the control group (median, 9.85 mM; range, 9.26–11.0 mM). The N‐acetylaspartate concentration was significantly reduced in seven of the nine patients studied. The reduction of the N‐acetylaspartate‐creatine ratio from the lentiform nucleus in the SRO group may reflect neuronal loss, occurring predominantly in the globus pallidus. Proton magnetic resonance spectroscopy may be a useful, noninvasive technique to help differentiate the various parkinsonian syndromes.

Url:

https://api.istex.fr/document/2842B82D4079CFF7DD0CF850DC5599DA665D0A52/fulltext/pdf

DOI: 10.1002/mds.870120525

Affiliations:

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Proton magnetic resonance spectroscopy in steele‐richardson‐olszewski syndrome</title>
<author><name sortKey="Davie, Charles A" sort="Davie, Charles A" uniqKey="Davie C" first="Charles A." last="Davie">Charles A. Davie</name>
</author>
<author><name sortKey="Barker, Gareth J" sort="Barker, Gareth J" uniqKey="Barker G" first="Gareth J." last="Barker">Gareth J. Barker</name>
</author>
<author><name sortKey="Machado, Christine" sort="Machado, Christine" uniqKey="Machado C" first="Christine" last="Machado">Christine Machado</name>
</author>
<author><name sortKey="Miller, David H" sort="Miller, David H" uniqKey="Miller D" first="David H." last="Miller">David H. Miller</name>
</author>
<author><name sortKey="Lees" sort="Lees" uniqKey="Lees" last="Lees">Lees</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:2842B82D4079CFF7DD0CF850DC5599DA665D0A52</idno>
<date when="1997" year="1997">1997</date>
<idno type="doi">10.1002/mds.870120525</idno>
<idno type="url">https://api.istex.fr/document/2842B82D4079CFF7DD0CF850DC5599DA665D0A52/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002922</idno>
<idno type="wicri:Area/Istex/Curation">002922</idno>
<idno type="wicri:Area/Istex/Checkpoint">003899</idno>
<idno type="wicri:doubleKey">0885-3185:1997:Davie C:proton:magnetic:resonance</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:9380064</idno>
<idno type="wicri:Area/PubMed/Corpus">004592</idno>
<idno type="wicri:Area/PubMed/Curation">004592</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004591</idno>
<idno type="wicri:Area/Ncbi/Merge">004D91</idno>
<idno type="wicri:Area/Ncbi/Curation">004D91</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004D91</idno>
<idno type="wicri:doubleKey">0885-3185:1997:Davie C:proton:magnetic:resonance</idno>
<idno type="wicri:Area/Main/Merge">008304</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:97-0489618</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">003175</idno>
<idno type="wicri:Area/PascalFrancis/Curation">003649</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">003167</idno>
<idno type="wicri:doubleKey">0885-3185:1997:Davie C:proton:magnetic:resonance</idno>
<idno type="wicri:Area/Main/Merge">008522</idno>
<idno type="wicri:Area/Main/Curation">005276</idno>
<idno type="wicri:Area/Main/Exploration">005276</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Proton magnetic resonance spectroscopy in steele‐richardson‐olszewski syndrome</title>
<author><name sortKey="Davie, Charles A" sort="Davie, Charles A" uniqKey="Davie C" first="Charles A." last="Davie">Charles A. Davie</name>
<affiliation wicri:level="3"><country>Royaume-Uni</country>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
<wicri:orgArea>National Hospital for Neurology and Neurosurgery</wicri:orgArea>
</affiliation>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>NMR Research Unit, Institute of Neurology, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Barker, Gareth J" sort="Barker, Gareth J" uniqKey="Barker G" first="Gareth J." last="Barker">Gareth J. Barker</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>NMR Research Unit, Institute of Neurology, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Machado, Christine" sort="Machado, Christine" uniqKey="Machado C" first="Christine" last="Machado">Christine Machado</name>
<affiliation wicri:level="3"><country>Royaume-Uni</country>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
<wicri:orgArea>National Hospital for Neurology and Neurosurgery</wicri:orgArea>
</affiliation>
</author>
<author><name sortKey="Miller, David H" sort="Miller, David H" uniqKey="Miller D" first="David H." last="Miller">David H. Miller</name>
<affiliation wicri:level="3"><country>Royaume-Uni</country>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
<wicri:orgArea>National Hospital for Neurology and Neurosurgery</wicri:orgArea>
</affiliation>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>NMR Research Unit, Institute of Neurology, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lees" sort="Lees" uniqKey="Lees" last="Lees">Lees</name>
<affiliation wicri:level="3"><country>Royaume-Uni</country>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
<wicri:orgArea>National Hospital for Neurology and Neurosurgery</wicri:orgArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1997-09">1997-09</date>
<biblScope unit="vol">12</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="767">767</biblScope>
<biblScope unit="page" to="771">771</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">2842B82D4079CFF7DD0CF850DC5599DA665D0A52</idno>
<idno type="DOI">10.1002/mds.870120525</idno>
<idno type="ArticleID">MDS870120525</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aspartic Acid (analogs & derivatives)</term>
<term>Aspartic Acid (analysis)</term>
<term>Basal Ganglia (chemistry)</term>
<term>Basal Ganglia (pathology)</term>
<term>Basal ganglia</term>
<term>Basal ganglion</term>
<term>Case-Control Studies</term>
<term>Choline (analysis)</term>
<term>Creatine (analysis)</term>
<term>Diagnosis, Differential</term>
<term>Exploration</term>
<term>Globus Pallidus (pathology)</term>
<term>Human</term>
<term>Humans</term>
<term>Magnetic Resonance Imaging</term>
<term>Magnetic Resonance Spectroscopy</term>
<term>Magnetic resonance imaging</term>
<term>Middle Aged</term>
<term>NMR spectrometry</term>
<term>Nuclear magnetic resonance imaging</term>
<term>N‐acetylaspartate</term>
<term>Progressive</term>
<term>Progressive supranuclear palsy</term>
<term>Spectroscopy</term>
<term>Supranuclear Palsy, Progressive (diagnosis)</term>
<term>Supranuclear ophthalmoplegia</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Aspartic Acid</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>Aspartic Acid</term>
<term>Choline</term>
<term>Creatine</term>
</keywords>
<keywords scheme="MESH" qualifier="chemistry" xml:lang="en"><term>Basal Ganglia</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Supranuclear Palsy, Progressive</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Basal Ganglia</term>
<term>Globus Pallidus</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Case-Control Studies</term>
<term>Diagnosis, Differential</term>
<term>Humans</term>
<term>Magnetic Resonance Imaging</term>
<term>Magnetic Resonance Spectroscopy</term>
<term>Middle Aged</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Exploration</term>
<term>Homme</term>
<term>Imagerie RMN</term>
<term>Noyau gris central</term>
<term>Ophtalmoplégie supranucléaire</term>
<term>Progressif</term>
<term>Spectrométrie RMN</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Proton magnetic resonance spectroscopy, localized to the lentiform nucleus, was carried out in nine patients with a clinical diagnosis of Steele‐Richardson‐Olszewski syndrome (SRO) and in eight healthy age‐matched controls. Three of the nine SRO patients had a so‐called “eye of the tiger sign” with high signal in the globus pallidus surrounded by a ring of low signal on T2 weighted magnetic resonance imaging previously only reported in Hallervorden‐Spatz disease. One of these patients had pathologically proven SRO at postmortem. The SRO group showed a significant reduction in the median concentration from N‐acetyl groups (median, 6.87 mM; range, 4.92–10.59 mM; p < 0.015) compared with the control group (median, 9.85 mM; range, 9.26–11.0 mM). The N‐acetylaspartate concentration was significantly reduced in seven of the nine patients studied. The reduction of the N‐acetylaspartate‐creatine ratio from the lentiform nucleus in the SRO group may reflect neuronal loss, occurring predominantly in the globus pallidus. Proton magnetic resonance spectroscopy may be a useful, noninvasive technique to help differentiate the various parkinsonian syndromes.</div>
</front>
</TEI>
<affiliations><list><country><li>Royaume-Uni</li>
</country>
<region><li>Angleterre</li>
<li>Grand Londres</li>
</region>
<settlement><li>Londres</li>
</settlement>
</list>
<tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Davie, Charles A" sort="Davie, Charles A" uniqKey="Davie C" first="Charles A." last="Davie">Charles A. Davie</name>
</region>
<name sortKey="Barker, Gareth J" sort="Barker, Gareth J" uniqKey="Barker G" first="Gareth J." last="Barker">Gareth J. Barker</name>
<name sortKey="Davie, Charles A" sort="Davie, Charles A" uniqKey="Davie C" first="Charles A." last="Davie">Charles A. Davie</name>
<name sortKey="Lees" sort="Lees" uniqKey="Lees" last="Lees">Lees</name>
<name sortKey="Machado, Christine" sort="Machado, Christine" uniqKey="Machado C" first="Christine" last="Machado">Christine Machado</name>
<name sortKey="Miller, David H" sort="Miller, David H" uniqKey="Miller D" first="David H." last="Miller">David H. Miller</name>
<name sortKey="Miller, David H" sort="Miller, David H" uniqKey="Miller D" first="David H." last="Miller">David H. Miller</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005276 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005276 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:2842B82D4079CFF7DD0CF850DC5599DA665D0A52
   |texte=   Proton magnetic resonance spectroscopy in steele‐richardson‐olszewski syndrome
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

Proton magnetic resonance spectroscopy in steele‐richardson‐olszewski syndrome

Proton magnetic resonance spectroscopy in steele‐richardson‐olszewski syndrome

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.